← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

M 10b5-1 Plan

$ Value

$1.3M

Shares

13,835

Price

$91

Filed

Nov 17

Insider

Name

LEIDEN JEFFREY M

Title

Executive Chairman

CIK

0001242825

Roles

Director Officer

Transaction Details

Transaction Date

2025-11-14

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

37,861

Footnotes

Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 8/6/2025. | Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. | Open market sales reported on this line occurred at a weighted average price of $440.22 (range $440.00 to $440.99). | Open market sales reported on this line occurred at a weighted average price of $441.05 (range $441.00 to $441.10). | Open market sales reported on this line occurred at a weighted average price of $440.30 (range $440.00 to $440.99). | Open market sales reported on this line occurred at a weighted average price of $441.35 (range $441.00 to $441.99). | Fully vested.

Filing Info

Accession No.

0000875320-25-000234

Form Type

4

Issuer CIK

0000875320

LEIDEN JEFFREY M's History

Date Ticker Type Value
2026-02-18 VRTX F $1.4M
2026-02-17 VRTX A $0
2026-01-22 VRTX A $0
2025-12-04 VRTX M $91
2025-12-04 VRTX M $0
2025-12-03 VRTX M $5.5M
2025-12-03 VRTX $2.0M
2025-12-03 VRTX $582K
2025-12-03 VRTX $1.1M
2025-12-03 VRTX $1.9M

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-02-17
LEIDEN JEFFREY M
Executive Chairman
2026-02-18
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
2026-02-17
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Bhatia Sangeeta N. $133K 2026-02-13
Kewalramani Reshma
CEO & President
2026-02-17
Biller Jonathan
EVP and Chief Legal Officer
$3.2M 2026-02-18
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
$1.4M 2026-02-18
Bozic Carmen
EVP and CMO
$1.1M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$439K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
$1.7M 2026-02-18
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
$2.2M 2026-02-18
McKechnie Duncan
EVP, Chief Commercial Officer
2026-02-17
Bunnage Mark E.
EVP, Chief Scientific Officer
$2.7M 2026-02-18